The U.S. Food and Drug Administration has approved the innovative drug Velcade as a treatment for myeloma. Made by Millennium Pharmaceuticals, Velcade was approved for helping patients who have failed at least two other therapies. The injectable drug is the first in a new class of anti-cancer agents known as proteasome inhibitors
(
Read more... )